The race to COVID-19 vaccines and treatments continues, with multiple clinical trials now in the final stages of testing. While the research is moving rapidly, it’s not without challenges. Two different trials were paused recently over potential safety concerns.
On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, discusses current COVID-19 clinical trials. Dr. Poland also covers the possibility of reinfection with COVID-19, and the importance of getting a flu vaccination to protect yourself from influenza during the pandemic.
This interview originally aired October 21, 2020.
Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding along with guidelines and recommendations may have changed since the original publication date. For more information and all your COVID-19 coverage, go to the Mayo Clinic News Network: [ Ссылка ]
For the safety of our patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was either recorded prior to COVID-19 or recorded in a non-patient care area where social distancing and other safety protocols were followed.
Dr. Poland has served as a consultant for Merck & Co. Inc., Medicago Inc., GlaxoSmithKline plc, Sanofi Pasteur, Emergent BioSolutions Inc., Dynavax Technologies Corp., Genentech Inc., Eli Lilly and Co., Kentucky BioProcessing Inc. and Genevant Sciences Corp., and Janssen Pharmaceuticals Inc. He is a paid scientific adviser for Johnson & Johnson. Honoraria: Elsevier.
